FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38702911000001105: Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1538061000001111 Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1538071000001118 Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) Is a Hydroxychloroquine 300mg tablets true Inferred relationship Existential restriction modifier
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) Has specific active ingredient Hydroxychloroquine sulfate true Inferred relationship Existential restriction modifier
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has AMP True Hydroxychloroquine 300mg tablets (Blackrock Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start